ผลงานตีพิมพ์ใน PubMed.gov รวมทั้งหมด 29 เรื่อง คือ

1.Open-label Phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L.

2.Double-blind, placebo-controlled, 1:1 randomized Phase III clinical trial of Immunoxel honey lozenges as an adjunct immunotherapy in 269 patients with pulmonary tuberculosis. 

3.Randomized, placebo-controlled Phase II trial of heat-killed Mycobacterium vaccae (Immodulon batch) formulated as an oral pill (V7). 

4.Randomized, placebo-controlled phase II trial of heat-killed Mycobacterium vaccae (Longcom batch) formulated as an oral pill (V7). 

5.Adjunct immune therapy of first-diagnosed TB, relapsed TB, treatment-failed TB, multidrug-resistant TB and TB/HIV. 

6.Clinical validation of sublingual formulations of Immunoxel (Dzherelo) as an adjuvant immunotherapy in treatment of TB patients

7.Immune approaches in tuberculosis therapy: a brief overview. 

8.Phase IIb randomized trial of adjunct immunotherapy in patients with first-diagnosed tuberculosis, relapsed and multi-drug-resistant (MDR) TB. 

9.Adjunct oral immunotherapy in patients with re-treated, multidrug-resistant or HIV-coinfected TB. 

10.Adjunctive therapy with V-5 Immunitor (V5) for the treatment of tuberculosis patients: a meta-analysis. 

11.Adjunct immune therapy of first-diagnosed TB, relapsed TB, treatment-failed TB, multidrug-resistant TB and TB/HIV. 

12.Adjunct oral immunotherapy in patients with re-treated, multidrug-resistant or HIV-coinfected TB. 

13.Safety and efficacy trial of adipose-tissue derived oral preparation V-6 Immunitor (V-6): results of open-label, two-month, follow-up study. 

14.Effect of oral immunization with pooled antigens derived from adipose tissue on atherosclerosis and obesity indices. 

15.Clinical experience with therapeutic vaccines designed for patients with hepatitis. 

16.Serodeconversion of HIV antibody-positive AIDS patients following treatment with V-1 Immunitor. 

17.Open-label trial of therapeutic immunization with oral V-5 Immunitor (V5) vaccine in patients with chronic hepatitis C. 

18.Oral vaccination: where we are? 

19.Therapeutic AIDS vaccines. 

20.Prolonged survival of end-stage AIDS patients immunized with therapeutic HIV vaccine V-1 Immunitor. 

21.[AIDS vaccines and immunotherapy of infertility]. 

22.Phase II placebo-controlled study of V-1 Immunitor as a therapeutic modality for treatment of HIV. 

23.Effect of an oral therapeutic HIV-1 vaccine on AIDS patients with CD4 count above 250 cells/mm3. 

24.Mucosal AIDS vaccines. 

25.Increased body weight and improved quality of life in AIDS patients following V-1 Immunitor administration. 

26.Low-cost anti-HIV compounds: potential application for AIDS therapy in developing countries. 

27.V-1 Immunitor: oral therapeutic AIDS vaccine with prophylactic potential. 

28.Survival of end-stage AIDS patients receiving V-1 Immunitor. 

29.Safety and efficacy of an oral HIV vaccine (V-1 Immunitor) in AIDS patients at various stages of the disease.